Our efforts to promote diversity focus on three main areas: management*, ...
Handling of the active pharmaceutical ingredient (API) and environmental ...
Dissemination of Medical Information Participating in Relay for Life...
Governance We recognize the preservation of the global environment as ...
We are making efforts to meet unmet medical needs and contribute to medical...
Compliance Promotion System To strengthen our compliance system, we ha...
Sustainability Report 2025 Sustainability Report 2025 Susta...
Our Position on Biodiversity Initiatives to Reduce Negative Impacts ...
Based on our corporate philosophy of "Dedicated to the Fight against D...
We have organized a nature positive sub-committee (formerly the resource ...
In November 2017, we participated in the United Nations Global Compact (U...
We conduct environmental efficiency assessments to quantitatively measure t...
DE&I Initiatives (Promotion of diverse human resources) Other Init...
The total water intake amount in FY2024 was 202.8 thousand m3, an increa...
Targets Progress Initiatives Initiatives for Pharmaceuticals Ext...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
In the Water Security survey conducted by CDP, a global environmental no...
Basic Policy for Human Rights Human Rights Due Diligence Access to R...
We implement all the principles of the Corporate Governance Code stipulat...
Collaboration with business partners is essential to reducing Scope 3 ...
Water is an important resource for maintaining people's lives and health....
Basic Policy for Enterprise Risk Management (ERM) In order to ensu...
In October 2023, we rolled out the Global HR System with the aim of enabl...
